CLINICAL_TRIALS
trial_result
· 2019-03-11
Clinical Trial Update: A Long Term Extension Study of E2080 in Lennox-Gastaut Patients [Phase 3]
Summary
Phase 3 long-term extension study of E2080 in Lennox-Gastaut syndrome completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Co., Ltd. | Conditions: Lennox-Gastaut Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2019-03-11